Image_3_Fas/FasL Contributes to HSV-1 Brain Infection and Neuroinflammation.jpeg
The Fas/FasL pathway plays a key role in immune homeostasis and immune surveillance. In the central nervous system (CNS) Fas/FasL is involved in axonal outgrowth and adult neurogenesis. However, little is known about the role of the Fas/FasL pathway in herpes encephalitis. In this study, we used a neuropathogenic clinical strain of herpes simplex virus type 1 (HSV-1) to explore infection-induced inflammation and immune responses in the mouse brain and the role of Fas/FasL in antiviral CNS immunity. HSV-1 CNS infection induced the infiltration of Fas- FasL-bearing monocytes and T cells in the brain and also to an up-regulation of Fas and FasL expression on resident astrocytes and microglia within infected sites. Upon infection, Fas- and FasL-deficient mice (lpr and gld) were partially protected from encephalitis with a decreased morbidity and mortality compared to WT mice. Fas/FasL deficiency promoted cell-mediated immunity within the CNS. Fas receptor stimulation abrogated HSV-1 induced activation and inflammatory reactions in microglia from WT mice, while lack of Fas or FasL led to a more pronounced activation of monocytes and microglia and also to an enhanced differentiation of these cells into a pro-inflammatory M1 phenotype. Furthermore, the specific immune system was more efficient in Fas- and FasL-deficient mice with significantly higher numbers of infiltrating HSV-1-specific cytotoxic T cells in the brain. Our data indicate that the Fas/FasL pathway leads to excessive neuroinflammation during HSV-1 infection, which is associated with a diminished anti-viral response and an excessive neuroinflammation.
History
References
- https://doi.org//10.1016/j.tim.2020.03.003
- https://doi.org//10.1038/nature07606
- https://doi.org//10.1084/jem.184.4.1513
- https://doi.org//10.4049/jimmunol.1000930
- https://doi.org//10.1016/j.ccr.2008.02.003
- https://doi.org//10.1084/jem.20132423
- https://doi.org//10.1023/A%3A1025317516396
- https://doi.org//10.4161/cc.8.6.7906
- https://doi.org//10.1038/ncb916
- https://doi.org//10.1038/sj.cdd.4401720
- https://doi.org//10.1016/j.stem.2009.05.004
- https://doi.org//10.1128/JVI.01136-07
- https://doi.org//10.1128/JVI.74.5.2447-2450.2000
- https://doi.org//10.1099/0022-1317-83-9-2109
- https://doi.org//10.1080/13550280490521122
- https://doi.org//10.1371/journal.pone.0070308
- https://doi.org//10.1128/JCM.43.5.2058-2064.2005
- https://doi.org//10.4049/jimmunol.1600207
- https://doi.org//10.1016/S0306-4522%2898%2900407-2
- https://doi.org//10.1038/cddis.2011.14
- https://doi.org//10.1016/j.bbi.2011.07.235
- https://doi.org//10.1186/s12974-019-1576-3
- https://doi.org//10.1371/journal.ppat.1005028
- https://doi.org//10.1128/JVI.01428-20
- https://doi.org//10.1111/bph.13139
- https://doi.org//10.1038/35037728
- https://doi.org//10.1128/JVI.02488-08
- https://doi.org//10.1128/JVI.01864-13
- https://doi.org//10.1016/j.immuni.2010.01.011
- https://doi.org//10.1111/cns.12575
- https://doi.org//10.3390/ijms21145150
- https://doi.org//10.3389/fimmu.2017.01216
- https://doi.org//10.1038/cddis.2017.139
- https://doi.org//10.3390/v12121354
- https://doi.org//10.1007/s00705-010-0712-2
- https://doi.org//10.1099/0022-1317-83-11-2779
- https://doi.org//10.1128/JVI.01791-10
- https://doi.org//10.1155/2019/2302835
- https://doi.org//10.1155/2015/435140
- https://doi.org//10.1128/JVI.76.7.3202-3211.2002
- https://doi.org//10.3109/13550289909045373
- https://doi.org//10.1002/glia.22689
- https://doi.org//10.1093/infdis/jiv771
- https://doi.org//10.4049/jimmunol.1700145
- https://doi.org//10.3389/fimmu.2018.02932
- https://doi.org//10.1002/rmv.1848
- https://doi.org//10.1016/j.jneuroim.2009.09.013
- https://doi.org//10.1007/s12035-015-9593-4
- https://doi.org//10.1186/1742-2094-11-98
- https://doi.org//10.1128/JVI.00525-18
- https://doi.org//10.1172/JCI97229
- https://doi.org//10.3390/brainsci11040466
- https://doi.org//10.1128/JVI.00578-17
- https://doi.org//10.1371/journal.ppat.1008971
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity